Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Dark-adapted Threshold of Full-field Stimulus Test in Ultra-low Vision Patients with Retinitis Pigmentosa
Author Affiliations & Notes
  • Kaoru Fujinami
    Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Meguro-ku, Tokyo, Japan
    University College London Institute of Ophthalmology, London, United Kingdom
  • Yu Fujinami-Yokokawa
    Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Meguro-ku, Tokyo, Japan
    University College London Institute of Ophthalmology, London, United Kingdom
  • Yasutaka Suzuki
    Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Meguro-ku, Tokyo, Japan
  • Jeffrey Farmer
    Diagnosys LLC, Boston, Massachusetts, United States
  • Kazushige Tsunoda
    Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Meguro-ku, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Kaoru Fujinami Astellas Pharma Inc, Kubota Pharmaceutical Holdings Co., Ltd, Acucela Inc., Janssen Pharm, Alnylam Pharmaceuticals, Novartis International AG, Saliogen therapeutics, Belite Bio, Restore Vision, FREST, Takara Bio, AAvantgarde, Chugai pharmaceutical., Code C (Consultant/Contractor), Astellas Pharma Inc, Janssen Pharm, National Institute for Health and Care Research, Code F (Financial Support), Astellas Pharma Inc, personal fees from Kubota Pharmaceutical Holdings Co., Ltd., personal fees from Acucela Inc., personal fees from SANTEN Company Limited, personal fees from Senju pharmaceutical co. ltd, personal fees from Novartis International AG, personal fees from Foundation Fighting Blindness, personal fees from Japanese Ophthalmology Society, personal fees from Japan Retinitis Pigmentosa Society. , Code R (Recipient); Yu Fujinami-Yokokawa None; Yasutaka Suzuki None; Jeffrey Farmer Diagnosys, Code E (Employment); Kazushige Tsunoda None
  • Footnotes
    Support  grants from National Hospital Organization Network Research Fund (H30-NHO-Sensory Organs-03)
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5861. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kaoru Fujinami, Yu Fujinami-Yokokawa, Yasutaka Suzuki, Jeffrey Farmer, Kazushige Tsunoda; Dark-adapted Threshold of Full-field Stimulus Test in Ultra-low Vision Patients with Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5861.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Full-field stimulus test/full-field stimulus threshold (FST) is a psychophysical technique designed for the measurement of visual function in low vision. We describe the distribution of luminance thresholds in subjects with severe retinitis pigmentosa (RP), aiming to establish a deep phenotyping protocol.

Methods : RP patients with ultra-low vision (ULV) showing severe visual acuity decline (counting fingers or worse) were enrolled. Comprehensive ophthalmological examinations were performed, including full-field electroretinograms (ffERGs) recorded according to the ISCEV standard. Full-field color stimuli were generated by the Diagnosys Profile ganzfeld ColorDome (Diagnosys, LLC, MA) which utilizes narrow-band LEDs of 448 nm (blue), 530nm (green), and 627 nm (red). FST was performed according to the previously published method (Klein, Birch 2009). The dark-adapted color FST was performed after 45 minutes dark adaptation: (i) blue; (ii) red; and (iii) white stimulus. The FST data of 20 healthy subjects were obtained for comparison with those of ULV RP patients.

Results : The median age of onset/examination of 51 eyes from 27 ULV RP patients was 9.0 (range, 0 to 40)/53.0 (12 to 83). The median visual acuity of 51 eyes was 2.22 (range, 1.10 to 3.00) LogMAR unit. The full-field ERGs were undetectable both in dark-adapted and light-adapted conditions in all patients. The median value for blue/red/white FST was -1.93(range, -4.97 to 1.04)/-2.54(-7.17 to 0.17)/-2.06(-6.51 to 5.93)log10 cd.s.m-2 in 51 ULV RP eyes. The median value of thresholds for blue/red/white FST was -7.70(-8.33 to -6.93)/-5.32(-6.24 to -4.82)/-7.11(-7.62 to -6.51) log10 cd.s.m-2 in the 40 healthy eyes. FST revealed a significantly different range of thresholds for each colour stimulus between ULV RP eyes and healthy eyes.

Conclusions : Quantitative assessment of the sensitivity of the visual field was available with FST for patients with ULV RP demonstrating undetectable ERGs, in keeping with previous reports (Roman AJ et al. Prog Retin Eye Res. 2021; Klein et al. Doc Ophthalmol. 2019). The broader distribution of luminance thresholds was illustrated in ULV RP patients, which was significantly higher than that of healthy subjects. These data would help monitor and counsel patients, as well as in the assessment of visual function in therapeutic trials.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×